Business Context and Reporting Period
Amplitech Group, Inc. filed a Form 8-K on April 15, 2021, reporting the entry into material definitive agreements for a registered direct offering. The company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC under the symbols AMPG (Common Stock) and AMPGW (Warrants).
Key Financial Metrics and Transaction Details
- Offering Size: 2,715,000 shares of common stock.
- Purchase Price: $8.48 per share.
- Gross Proceeds: Approximately $23.0 million (before fees and expenses).
- Warrants Issued: 1,900,500 warrants to purchase common stock at an exercise price of $8.48 per share with a five-year term.
- Placement Agent Fees: 8% of gross proceeds plus $60,000 in out-of-pocket expenses payable to Maxim Group LLC.
- Expected Closing Date: On or about April 16, 2021.
Material Changes and Agreements
The filing details a significant capital raise via a registered direct offering. Key contractual obligations include:
- Lock-Up Period: The Company, executive officers, and directors agreed not to sell or dispose of common stock or convertible securities until June 19, 2021, subject to limited exceptions.
- Variable Rate Transactions: The Company agreed not to engage in variable rate transactions for one year from the closing of the offering.
- Warrant Terms: Warrants are exercisable on a "cashless" basis in certain circumstances until a prospectus supplement or Form S-3 registration statement is filed for their resale.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, revenue outlook, or management commentary regarding future operational performance. The primary focus is the execution of the financing transaction. Risks associated with the transaction include the dilution of existing shareholders due to the issuance of new shares and warrants, and the obligation to pay placement agent fees which will reduce net proceeds.
Investor Verification Checklist
- Verify the actual closing date and final net proceeds after deducting the 8% placement fee and expenses.
- Confirm the filing of the prospectus supplement and Form S-3 registration statement to enable cashless warrant exercise.
- Review the definitive Securities Purchase Agreement (Exhibit 10.1) for specific exceptions to the lock-up period.
- Monitor the impact of the 2,715,000 new shares and 1,900,500 warrants on the company's fully diluted share count.